Thank you ⁦@VersatopeRx⁩ for supporting the Scholars SMDP visit to ⁦@UMassLowell⁩ today ⁦@IbraheemBadejo⁩

M2D2 #200kChallenge winner & resident company @VersatopeRX discuss their solution with MA Attorney General Maura Healey @MassAGO

Versatope will present their nano-vesicle RNA delivery technology at the upcoming Applications of Exosomes conference.

Versatope Expands Scientific Advisory Board with Dr. Drew Weissman and Board of Directors with Dr. James Kuo and Jeremy Gowler. @PennMedicine @UMassM2D2 @UMassLowell #biotech #vaccines #immunotherapy #medicalsciences https://t.co/PALKVchXte

Join me at #WVCUSA and attend this leading vaccine event completely FREE! From May 4-6, learn from industry experts at the largest, most established meeting dedicated to vaccines. Register and claim your free ticket today!

Find Out How Versatope's Transformational Biotechnology Platform Can Display Multiple Viral Variants on a Single Vesicle #vaccines #infectiousdiseases #fluvaccine #covidvaccine #biotechnology @VersatopeRx

How to Design a Vaccine that Gives Long Term Immunity Against Multiple Strains? It's All In The Nano-Vesicles https://t.co/qeBec735Y7 @VersatopeRx #vaccine #Innovation #fluvaccine #COVIDVaccine #biotech

Versatope's nanovesicle vaccine platform shows promise for capturing antigenic diversity, strain variation and favorable cost manufacturing #vaccines #infectiousdiseases @VersatopRX https://t.co/onbhi07xRg

What the World Needs Now: A thermostable #CovidVaccine that can scale up rapidly without the need for cold chain distribution. Check out @VersatopeRx multi-strain vaccine design using probiotic vesicles. https://t.co/OpX47P2NzR #vaccine #innovation #influenza #biotech

How Versatope's vaccine can prime the immune system for long-term immunity against viruses. @VersatopeRx #vaccine #Innovation #fluvaccine #COVIDVaccine #biotech https://t.co/ZV3lI56x0S

How to Design a Vaccine that Gives Long Term Immunity Against Multiple Strains? It's All In The Vesicles https://t.co/DanXEdsp4w @VersatopeRx #vaccine #Innovation #fluvaccine #COVIDVaccine #biotech

Take a voyage inside Versatope's vaccine vesicles and learn how we design multi-strain vaccines using probiotic vesicles and why this gives us a competitive advantage over single strain vaccines https://t.co/OpX47P2NzR #vaccine #innovation #biotechnology #covid19 #fluvaccine

Does a reduction in mild COVID-19 symptoms warrant vaccine approval? #covid19testing #vaccine #fda #coronavirus #covid19

@VersatopeRx awarded grant to develop a novel vaccine for C. diff from the National Institute of Allergy and Infectious Diseases (NIAID). #cdiff @UMassM2D2 @MassBio @NIH https://t.co/9v3V0d2lEe

Versatope awarded grant to develop a novel vaccine for C. diff from the National Institute of Allergy and Infectious Diseases (NIAID). #cdiff @UMassM2D2 @MassBio https://t.co/j6UhzIstRj

The applicability of Versatope's platform expands into cell targeting, gene/drug delivery, biosensing, and bioremediation https://t.co/Z1c59yGIWU #vaccines #infectiousdiseases #drugdelivery #celltargeting

The worldwide flu vaccine market hit $5.2 billion in 2018 and is expected to grow to $7.5 billion by 2024 https://t.co/qviCK2zKhK #vaccines #infectiousdiseases #flu #influenza

Versatope Therapeutics is committed to revolutionizing immuno-therapy for infectious diseases, allergy and cancer https://t.co/Z1c59yGIWU #vaccines #infectiousdiseases #allergy #cancer @VersatopRX

Versatope's cutting edge vaccine technology induces long-term memory and cross-strain protection https://t.co/Z1c59yGIWU #vaccines #infectiousdiseases @VersatopRX

The Versatope management team consists of an A-list of seasoned business executives, and biotech experts, Ph.D. scientists, and a team of advisors with deep scientific and clinical expertise https://t.co/qviCK2zKhK #vaccines #infectiousdiseases #biotech @VersatopRX